EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)

Evaluating the Safety and Efficacy of Sirolimus Topical Gel 0.2% to Treat Acanthosis Nigricans

Kayla Zafar, Margaret Kabakova, David Bitterman, Lucie Joerg, Jared Jagdeo

Journal of Drugs in Dermatology · 01.07.2026 · 25 (7) · 615-620

DOI: 10.36849/jdd.9457 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift Journal of Drugs in Dermatology, online erschienen am 01.06.2026. Verfasst von Kayla Zafar und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Acanthosis Nigricans, Sirolimus, Dermatologic Agents.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acanthosis NigricansSirolimusDermatologic AgentsHumansFemaleGelsMaleAdultMiddle AgedTreatment OutcomePilot ProjectsQuality of LifeSkin PigmentationAdministration, CutaneousPatient Satisfaction

Substanzen

SirolimusGelsDermatologic Agents

Zitieren

APA

Zafar, K., Kabakova, M., Bitterman, D., Joerg, L., & Jagdeo, J. (2026). Evaluating the Safety and Efficacy of Sirolimus Topical Gel 0.2% to Treat Acanthosis Nigricans. Journal of Drugs in Dermatology, 25(7), 615-620. https://doi.org/10.36849/jdd.9457

Vancouver

Zafar K, Kabakova M, Bitterman D, Joerg L, Jagdeo J. Evaluating the Safety and Efficacy of Sirolimus Topical Gel 0.2% to Treat Acanthosis Nigricans. Journal of Drugs in Dermatology. 2026;25(7):615-620. doi:10.36849/jdd.9457

BibTeX
@article{Zafar2026,
  author = {Zafar, Kayla and Kabakova, Margaret and Bitterman, David and Joerg, Lucie and Jagdeo, Jared},
  title = {Evaluating the Safety and Efficacy of Sirolimus Topical Gel 0.2% to Treat Acanthosis Nigricans},
  journal = {Journal of Drugs in Dermatology},
  year = {2026},
  volume = {25},
  number = {7},
  pages = {615--620},
  doi = {10.36849/jdd.9457}
}
Kostenlos starten →